Literature DB >> 27974021

Experiences of alcohol consumption and taking antiretroviral medication among men living with HIV in Tshwane, South Africa.

Sebenzile Nkosi1, Eileen P Rich1, Connie T Kekwaletswe1, Neo K Morojele1,2,3.   

Abstract

Hazardous alcohol consumption may compromise optimal antiretroviral therapy (ART) adherence among patients. Adoption of hegemonic notions of masculinity may encourage health-risk behaviours, such as alcohol consumption, and discourage health-enhancing behaviours, such as ART adherence among men. This study aimed to explore linkages between masculinity, alcohol consumption, and taking ART medication among male ART recipients in South Africa. Male facilitators conducted five focus group discussions with 27 black male ART recipients aged between 28 and 65 years at five ART clinics. Eligibility criteria were: 18 years or older, at least three months on ART, and alcohol consumption in the past three months. Data were analysed inductively using thematic content analysis. The men demonstrated a masculinity that fostered commitment to taking ART. However, normative notions of masculinity in the men's social circles often compromised their timeous taking of medication. Fears of alcohol-ART interactions often led to intentional non-adherence to ART when drinking. Finally, healthcare provider-patient power dynamics seemed to prevent the men from discussing their challenges regarding alcohol use and ART adherence with their healthcare providers. Interventions that focus on addressing harmful hegemonic notions of masculinity among men are needed in community settings such as drinking establishments where men tend to socialise. Patient-centred approaches which enhance men's sense of involvement in their treatment are needed in healthcare settings.

Entities:  

Keywords:  HIV; South Africa; alcohol consumption; antiretroviral therapy; hegemonic masculinity

Mesh:

Substances:

Year:  2016        PMID: 27974021     DOI: 10.2989/16085906.2016.1255651

Source DB:  PubMed          Journal:  Afr J AIDS Res        ISSN: 1608-5906            Impact factor:   1.300


  6 in total

1.  Alcohol-related intentional nonadherence to antiretroviral therapy among people living with HIV, Cape Town, South Africa.

Authors:  Seth Kalichman; Catherine Mathews; Ellen Banas; Moira Kalichman
Journal:  AIDS Care       Date:  2019-03-18

2.  The Unaddressed Needs of Alcohol-Using Couples on Antiretroviral Therapy in Malawi: Formative Research on Multilevel Interventions.

Authors:  Amy A Conroy; Allison Ruark; Stacey A McKenna; Judy Y Tan; Lynae A Darbes; Judith A Hahn; James Mkandawire
Journal:  AIDS Behav       Date:  2020-06

3.  Heavy episodic drinking and HIV disclosure by HIV treatment status among People with HIV in IeDEA Cameroon.

Authors:  Kathryn E Lancaster; Molly Remch; Anastase Dzudie; Rogers Ajeh; Adebola Adedimeji; Denis Nash; Kathryn Anastos; Marcel Yotebieng; Eric Walter Yone-Pefura; Denis Nsame; Angela Parcesepe
Journal:  Int J Drug Policy       Date:  2021-09-15

4.  Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities.

Authors:  Kathryn E Lancaster; Angela Hetrick; Antoine Jaquet; Adebola Adedimeji; Lukoye Atwoli; Donn J Colby; Angel M Mayor; Angela Parcesepe; Jennifer Syvertsen
Journal:  J Virus Erad       Date:  2018-11-15

5.  A conceptual model of alcohol use and adherence to antiretroviral therapy: systematic review and theoretical implications for mechanisms of action.

Authors:  Sarah E Woolf-King; Alan Z Sheinfil; Jeremy Ramos; Jacklyn D Foley; Dezarie Moskal; Madison Firkey; David Kellen; Stephen A Maisto
Journal:  Health Psychol Rev       Date:  2020-08-20

6.  The rebellious man: Next-of-kin accounts of the death of a male relative on antiretroviral therapy in sub-Saharan Africa.

Authors:  Morten Skovdal; Robert Ssekubugu; Constance Nyamukapa; Janet Seeley; Jenny Renju; Joyce Wamoyi; Mosa Moshabela; Kenneth Ondenge; Alison Wringe; Simon Gregson; Basia Zaba
Journal:  Glob Public Health       Date:  2019-01-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.